share_log

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 272.0% in October

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 272.0% in October

HAvn生命科學公司(場外市場代碼:HAVLF)空頭股數10月份上漲272.0
Financial News Live ·  2022/11/12 12:31

HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 9,300 shares, an increase of 272.0% from the October 15th total of 2,500 shares. Based on an average trading volume of 10,200 shares, the days-to-cover ratio is currently 0.9 days.

HAvn Life Science Inc.(場外交易市場代碼:HAVLF-GET Rating)是10月份空頭股數大幅增長的接受者。截至10月31日,空頭股數共有9,300股,比10月15日的2,500股增加了272.0%。以10,200股的平均成交量計算,目前天數與回補比率為0.9天。

HAVN Life Sciences Stock Performance

有生命科學類股表現

Shares of HAVLF traded up $0.01 during trading hours on Friday, reaching $0.07. 2,206 shares of the company's stock traded hands, compared to its average volume of 5,190. The firm's 50 day simple moving average is $0.11 and its 200-day simple moving average is $0.82. HAVN Life Sciences has a 12 month low of $0.05 and a 12 month high of $6.48.

在週五的交易時間裏,HAVLF的股價上漲了0.01美元,達到0.07美元。該公司股票成交量為2,206股,而平均成交量為5,190股。該公司的50日簡單移動均線切入位為0.11美元,200日簡單移動均線切入位為0.82美元。HAvn Life Sciences的股價為0.05美元的12個月低點,以及6.48美元的12個月高位。

Get
到達
HAVN Life Sciences
擁有生命科學學位
alerts:
警報:

About HAVN Life Sciences

關於HAVN生命科學

(Get Rating)

(獲取評級)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
HAVN生命科學公司是一家生物技術公司,從事從植物和真菌中提取的精神藥理產品的研究和開發。該公司還專注於開發從植物和真菌(包括裸子菌屬)中標準化和質量控制地提取精神活性化合物的方法。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
  • MarketBeat: Week in Review 11/7 – 11/11
  • Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
  • Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
  • Six Flags is a Ride You Don't Want to Get Stuck On
  • Hanesbrands May be Signaling a Bad Week for Retail Stocks
  • 免費獲取StockNews.com關於HAVN生命科學的研究報告(HAVLF)
  • MarketBeat:回顧中的一週11/7-11/11
  • 油價是股市拋售尚未結束的一個令人信服的原因
  • 中盤Neurocrine生物科學是井噴後的第三季度報告嗎?
  • 六面旗幟是一種你不想被困住的旅程
  • Hanesbrand可能發出零售類股本週表現不佳的信號

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《HAVN生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HAVN生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論